FDLI SmartBriefDesigned specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.&nbsp;Click&nbsp; <a href='http://www.smartbrief.com/fdli/index.jsp?sb_code=rss'>here</a> to subscribe.http://www.smartbrief.com/news/fdli?sb_code=rsshttp://www.smartbrief.com/images/xml/generic/logos/sb_logo.gifFDLI SmartBriefhttp://www.smartbrief.com/news/fdli?sb_code=rssen-us20 Nov 2009 11:43:45 CSTAstraZeneca submits Brilinta for FDA approvalhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DB926384D-F319-46BB-B82B-9A385F127369%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70AstraZeneca filed for FDA approval of Brilinta, a promising rival to blockbuster blood thinner Plavix.  -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DB926384D-F319-46BB-B82B-9A385F127369%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTDrugs & BiologicsProtein Sciences' FluBlok fails to gain FDA advisers' supporthttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D93B6BEBB-BBBD-478D-93B9-D20998669913%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70Protein Sciences failed to obtain endorsement from an FDA panel for its flu vaccine FluBlok and was asked to conduct more tri -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D93B6BEBB-BBBD-478D-93B9-D20998669913%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTDrugs & BiologicsFDA panel supports bolder label for Spiriva Handihalerhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D6AF14092-14B3-4B12-A6EB-C5433BCACDEE%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70An FDA advisory committee recommended that Boehringer Ingelheim's Spiriva Handihaler carry a revised label that includes the  -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D6AF14092-14B3-4B12-A6EB-C5433BCACDEE%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTDrugs & BiologicsFDA accuses Web sites of selling fake, unapproved drugshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D3BECC2D5-74FF-45A3-8079-A2F4BEBBC6AE%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70The FDA warned 136 Web sites as well as their Internet service providers and domain-name registrars for allegedly selling fak -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D3BECC2D5-74FF-45A3-8079-A2F4BEBBC6AE%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTDrugs & BiologicsLatest Senate bill would cut tax on device firms by halfhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DBA686073-2D45-43EA-9A98-2AA3A633C09B%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70The Senate health reform bill introduced on Wednesday by Senate Majority Leader Harry Reid, D-Nev., would impose $2 billion i -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DBA686073-2D45-43EA-9A98-2AA3A633C09B%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTHealth Care in TransitionAdvanced Cell Technology seeks FDA clearance for stem cell trialhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D0710938E-F0DC-4F71-8D2D-685AAF8FF6B9%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70Advanced Cell Technology submitted an investigational new-drug application to conduct an early-stage trial of a stem cell the -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D0710938E-F0DC-4F71-8D2D-685AAF8FF6B9%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTBiotechnologyMd. stem cell agency gets record number of grant proposalshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D528993EE-0C08-4F45-8FDC-6A56068520CB%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70The Maryland Stem Cell Research Commission said the number of proposals it received for research grants reached its highest l -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D528993EE-0C08-4F45-8FDC-6A56068520CB%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTBiotechnologyStudy links moderate drinking and heart protectionhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DC7E56769-AA6A-4726-B504-975062E35657%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70Moderate drinking can cut the risk of heart disease in men by as much as one-third and benefit women as well, a Spanish study -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DC7E56769-AA6A-4726-B504-975062E35657%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTFood & Dietary IngredientsInsurers say mammogram guidelines won't affect policieshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D8E56DE43-1273-4D52-ADB0-11FA9AF97CAA%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70Medicare and private health insurers said they would not alter coverage of mammograms in reaction to the U.S.  -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D8E56DE43-1273-4D52-ADB0-11FA9AF97CAA%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTMedical DevicesFDA permits Endologix to test procedure for abdominal aortic aneurysmhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D36E571EF-55A0-4578-A268-524086DAF3D2%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70The FDA has granted Investigational Device Exemption conditional approval to Endologix to allow it to test a percutaneous pro -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D36E571EF-55A0-4578-A268-524086DAF3D2%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTMedical DevicesCD library and downloadable productshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DC47E2369-4FD4-4398-947F-B7EB1DACE6CB%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70FDLI records many of its programs, including the recently held Tobacco Legislation and Regulation conference.  -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3DC47E2369-4FD4-4398-947F-B7EB1DACE6CB%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTFDLI ItemsSponsorship, exhibiting and advertisinghttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D79BF5D84-FE02-411E-8C46-3DC0096F56AC%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70FDLI provides opportunities to market your organization and services to professionals in the FDA-regulated industries.  -More- 

Sr. Paralegal (Pharmaceutical Contracts/Transactions)
Endo Pharmaceuticals

]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D79BF5D84-FE02-411E-8C46-3DC0096F56AC%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTFDLI ItemsJonathan Winters, comedian, author and artisthttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D3BD6F2E6-C0B2-49BD-A7A2-F23702169396%26brief%3Dfdli%26sb_code%3Drss%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B70Nothing is impossible. Some things are just less likely than others. -More- ]]>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DACFC72EB-A4B6-41BB-A24B-790B83FE9B70%26copyid%3D3BD6F2E6-C0B2-49BD-A7A2-F23702169396%26brief%3Dfdli%26sb_code%3Drss%26campaign%3Drss&i=ACFC72EB-A4B6-41BB-A24B-790B83FE9B7020 Nov 2009 00:00:00 CSTSmartQuote